
|Articles|June 1, 2001
- Pharmaceutical Executive-06-01-2001
- Volume 0
- Issue 0
Emotion - Biotech Renaissance Man
Author(s)Gil Bashe
The founder of five biotech companies rarely pauses, even to rest. "I can do a lot of work when the rest of my family is sleeping," he reports. "Early in the morning or late at night, there are no phones, so I needn't divert my attention." His affable tone seems contrary to the relentless drive needed to support a lifelong pursuit of excellence, but his achievements speak for themselves.
Advertisement
Articles in this issue
about 25 years ago
Industry Under Investigationabout 25 years ago
Emotion - The New Brand Integratorabout 25 years ago
For Love of the Gameabout 25 years ago
Field of Dreamsabout 25 years ago
Workshop: Access Optionsabout 25 years ago
Emotion - The New Brand Integratorabout 25 years ago
Rx-to-OTC: Unwanted Attentionabout 25 years ago
Relocation: Coming to Americaabout 25 years ago
Stocks: Catching the Market Bluesabout 25 years ago
Gathering LightAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
How Exposed is The U.S. Pharmaceutical Supply Chain to China’s Updated Export Control Regulations?
2
Bristol Myers Squibb Expands Collaboration with Nvidia to Build AI Factory
3
Pharmaceutical Executive Daily: Bristol Myers Squibb Expands Partnership with Nvidia
4
Staying Ahead of Viral Evolution: Q&A with Robert Allen, Ph.D
5




